Method and apparatus for determining tumor shift during surgery using a stereo-optical three-dimensional surface-mapping system
US-9336592-B2 · May 10, 2016 · US
US11564639B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11564639-B2 |
| Application number | US-201414767836-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 13, 2014 |
| Priority date | Feb 13, 2013 |
| Publication date | Jan 31, 2023 |
| Grant date | Jan 31, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of generating corrected fluorescence data of concentrations of a targeted fluorophore in tissue of a subject includes administering first and second fluorescent contrast agents to the subject, the first contrast agent targeted to tissue of interest, the second agent untargeted. The tissue is illuminated with light of a first stimulus wavelength and first data is acquired at an appropriate emissions wavelength; the tissue is illuminated at a second stimulus wavelength and second data is acquired at a second emissions wavelength associated with the second agent, the first and second emissions wavelength differ. Difference data is generated by subtracting the second data from the first data. A system provides for stimulus and capture at multiple wavelengths, with image storage memory and subtraction code, to perform the method. Corrected data may form an fluorescence image, or is used to generate fluorescence tomographic images.
Opening claim text (preview).
What is claimed is: 1. A system for generating three dimensional images of bound fluorophore concentrations in tissue from difference data of the fluorescence response of a nontargeted fluorophore subtracted from the fluorescence response of a targeted fluorophore, the targeted and nontargeted fluorophores being different, comprising: a first apparatus configured for generating and illuminating tissue with light selectable between a nontargeted stimulus wavelength and a targeted stimulus wavelength; photodetector apparatus adaptable to capture nontargeted emissions data at a nontargeted set of emission wavelengths while the tissue is illuminated with light of the nontargeted stimulus wavelength, and to capture targeted emissions data at a targeted set of emission wavelengths while tissue is illuminated with light of the targeted stimulus wavelength, where at least the nontargeted and targeted stimulus wavelength are different wavelengths, and the nontargeted and targeted emissions wavelengths are different wavelengths; a memory configured to store the nontargeted emissions data and the targeted emissions data; a processor configured with machine readable code in the memory; the machine readable code comprising instructions for reconstructing bound fluorophore concentrations of a voxel-based three dimensional model of distribution of bound targeted fluorophore concentration in tissue from difference data derived by subtracting the nontargeted emissions data from the targeted emissions data. 2. The system of claim 1 further comprising apparatus configured for administering a contrast agent, the apparatus configured for administering a contrast agent containing a contrast agent comprising: a first contrast agent comprising a substance selected from the group consisting of a prodrug metabolizable into a targeted fluorophore and a tissue-selective agent comprising a targeted fluorophore; and a second contrast agent comprising a nontargeted fluorophore; wherein the first fluorophore emits light of the targeted emissions wavelength when stimulated by light of the targeted stimulus wavelength, and the nontargeted fluorophore emits light of the nontargeted emissions wavelength when stimulated by light of the nontargeted stimulus wavelength. 3. The system of claim 2 wherein the first contrast agent is a prodrug metabolizable into the targeted fluorophore. 4. The system of claim 1 wherein the machine readable code comprises instructions to scale an emissions data selected from the group selected from the nontargeted emissions data and the targeted emissions data prior to subtracting the nontargeted emissions data from the targeted emissions data.
Arrangements for scanning · CPC title
Artificial waveform generation or derivation, e.g. synthesizing signals from measured signals · CPC title
by measuring fluorescence emission · CPC title
Antibodies · CPC title
Medical imaging apparatus involving image processing or analysis (A61B1/00009, A61B6/52 and A61B8/52 take precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.